These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9354226)

  • 1. Management of incessant ventricular tachycardia in a 39-year-old woman with cardiomyopathy.
    Schuster MM
    Am J Crit Care; 1997 Nov; 6(6):467-71. PubMed ID: 9354226
    [No Abstract]   [Full Text] [Related]  

  • 2. Amiodarone versus implantable cardioverter defibrillator for asymptomatic nonsustained ventricular tachycardia in nonischemic dilated cardiomyopathy.
    Cawley PJ; Al-Khatib SM
    Am Heart J; 2004 May; 147(5):790-1. PubMed ID: 15131532
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare cause of graft dysfunction after a heart transplant.
    Zimmerman H; Nolan PE; Copeland JG; Sethi G
    Interact Cardiovasc Thorac Surg; 2010 Nov; 11(5):719-20. PubMed ID: 20724428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiomyopathy induced by incessant ventricular tachycardia ("tachycardiomyopathy"): cure after control of arrhythmia].
    Sternick EB; Bahia FC; Gontijo Filho B; Vrandecic MO
    Arq Bras Cardiol; 1992 Mar; 58(3):209-14. PubMed ID: 1340201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term management of the survivor of ventricular fibrillation or sustained ventricular tachycardia.
    Connolly SJ; Krahn A; Klein G
    Can J Cardiol; 2000 Jun; 16 Suppl C():20C-2C. PubMed ID: 10887273
    [No Abstract]   [Full Text] [Related]  

  • 7. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
    Della Bella P
    Ital Heart J Suppl; 2000 Aug; 1(8):1070-1. PubMed ID: 10993020
    [No Abstract]   [Full Text] [Related]  

  • 8. Say no to primary prophylaxis with implantable cardioverter-defibrillators in asymptomatic nonischemic dilated cardiomyopathy?
    Jayachandran JV; Zipes DP
    J Am Coll Cardiol; 2003 May; 41(10):1713-5. PubMed ID: 12767652
    [No Abstract]   [Full Text] [Related]  

  • 9. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
    Grimm W; Christ M; Bach J; Müller HH; Maisch B
    Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac manifestations in Emery-Dreifuss muscular dystrophy.
    Faiella W; Bessoudo R
    CMAJ; 2018 Dec; 190(48):E1414-E1417. PubMed ID: 30510046
    [No Abstract]   [Full Text] [Related]  

  • 11. Incessant ventricular tachycardia.
    Germano JJ; Padmanabhan VT; Cohen TJ
    J Invasive Cardiol; 2002 Jun; 14(6):354-7. PubMed ID: 12042632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular tachyarrhythmias (out of hospital cardiac arrests).
    Lang E; Al Raisi M
    Clin Evid; 2006 Jun; (15):295-300. PubMed ID: 16973013
    [No Abstract]   [Full Text] [Related]  

  • 13. A patient with recurrent atrial fibrillation and monomorphic ventricular tachycardia treated successfully with dronedarone.
    Fink A; Duray GZ; Hohnloser SH
    Europace; 2011 Feb; 13(2):284-5. PubMed ID: 20965881
    [No Abstract]   [Full Text] [Related]  

  • 14. Storms of ventricular tachyarrhythmias associated with primary hyperparathyroidism in a patient with dilated cardiomyopathy.
    Kolb C; Lehmann G; Schreieck J; Ndrepepa G; Schmitt C
    Int J Cardiol; 2003 Jan; 87(1):115-6. PubMed ID: 12468064
    [No Abstract]   [Full Text] [Related]  

  • 15. Irregular ventricular tachycardia underdetected by implantable cardioverter defibrillator device.
    Manolis AG; Kourouklis S; Chatzis D; Kouvelas K; Kyriakides Z
    Cardiol J; 2008; 15(3):281-3. PubMed ID: 18651422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone.
    Swanton H
    Br J Hosp Med; 1997 Oct 1-14; 58(7):329-32. PubMed ID: 9509054
    [No Abstract]   [Full Text] [Related]  

  • 17. Recurrent ventricular fibrillation during a febrile illness and hyperthermia in a patient with dilated cardiomyopathy and automatic implantable cardioverter defibrillator. An example of reversible electrical storm.
    D'Aloia A; Faggiano P; Brentana L; Boldini A; Curnis A; Bontempi L; Dei Cas L
    Int J Cardiol; 2005 Aug; 103(2):207-8. PubMed ID: 16080982
    [No Abstract]   [Full Text] [Related]  

  • 18. Drugs for ventricular arrhythmias in the era of the implantable cardioverter defibrillator.
    Peters NS
    Eur Heart J; 1999 Mar; 20(5):321-3. PubMed ID: 10206376
    [No Abstract]   [Full Text] [Related]  

  • 19. Proarrhythmic effect of 'Reverse Mode Switch' in a patient with dilated cardiomyopathy and drug-induced long QTc interval.
    De Maria E; Patrizi G; Cappelli S
    Europace; 2015 Mar; 17(3):423. PubMed ID: 25722477
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical assessment and management of patients with implanted cardioverter-defibrillators presenting to nonelectrophysiologists.
    Stevenson WG; Chaitman BR; Ellenbogen KA; Epstein AE; Gross WL; Hayes DL; Strickberger SA; Sweeney MO; ;
    Circulation; 2004 Dec; 110(25):3866-9. PubMed ID: 15611390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.